Originally reported by businesswire. Read more
Archive summary Clinical & research
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
LONDON & NEW YORK--(BUSINESS WIRE) $CMPS Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will participate in a panel entitled “Clinical Risk, Regulat
Newsletter
The weekly digest
Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.